Skip to content

Cefadroxil

    DEA Class; Rx

    Common Brand Names; Duricef, Ultracef

    • Cephalosporins, 1st Generation

    Oral first-generation cephalosporin. Spectrum includes gram-positive organisms with limited gram-negative coverage. Indicated for UTI, skin and skin structure infections, pharyngitis, and tonsillitis.

    Indicated for the treatment of urinary tract infection (UTI), including cystitis.

    For the treatment of skin and skin structure infections including impetigo.
    For the treatment of group A beta-hemolytic streptococcal (GAS) pharyngitis (primary rheumatic fever prophylaxis) and tonsillitis.

    Documented hypersensitivity

    • Diarrhea
    • Abdominal pain
    • Dyspepsia
    • Nausea
    • Vomiting
    • Rash
    • Urticaria
    • Pseudomembranous colitis
    • Stevens-Johnson syndrome
    • Anaphylaxis
    • Transaminases increased
    • Neutropenia

    Adjust dose in severe renal insufficiency (high doses may cause CNS toxicity); prolonged use may result in superinfection

    Pregnancy Category: B

    Lactation: enters breast milk; use with caution

    Adults

    2 g/day PO.

    Elderly

    2 g/day PO.

    Adolescents

    30 mg/kg/day PO, not to exceed 2 g/day PO.

    Children

    30 mg/kg/day PO, not to exceed 2 g/day PO; 50 mg/kg PO x1, not to exceed 2 g PO, has been recommended for endocarditis prophylaxis.

    Infants

    30 mg/kg/day PO.

    Cefadroxil

    capsule

    • 500mg

    oral suspension

    • 250mg/5mL
    • 500mg/5mL

    tablet

    • 1g